Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Revenue (2016 - 2025)

Historic Revenue for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $1.5 billion.

  • Chemours' Revenue fell 86.21% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 billion, marking a year-over-year increase of 77.69%. This contributed to the annual value of $5.8 billion for FY2024, which is 487.0% down from last year.
  • According to the latest figures from Q3 2025, Chemours' Revenue is $1.5 billion, which was down 86.21% from $1.6 billion recorded in Q2 2025.
  • In the past 5 years, Chemours' Revenue ranged from a high of $1.9 billion in Q2 2022 and a low of $1.3 billion during Q4 2022
  • Its 5-year average for Revenue is $1.6 billion, with a median of $1.5 billion in 2023.
  • In the last 5 years, Chemours' Revenue soared by 5141.81% in 2021 and then plummeted by 1553.18% in 2023.
  • Quarter analysis of 5 years shows Chemours' Revenue stood at $1.6 billion in 2021, then decreased by 15.05% to $1.3 billion in 2022, then rose by 2.24% to $1.4 billion in 2023, then dropped by 0.66% to $1.4 billion in 2024, then grew by 10.01% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.6 billion for Q2 2025, and $1.4 billion during Q1 2025.